Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
King-Jones Heidy (CIK 1794898) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Buy SYRE (27,999 shares), Sell SYRE (4,845 shares), Sell SYRE (16,548 shares), Sell SYRE (6,206 shares), Sell SYRE (400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Buy | 27,999 | $405,986 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Sell | 4,845 | $418,608 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Sell | 16,548 | $1.4M |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Sell | 6,206 | $547,183 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Sell | 400 | $35,752 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Buy | 400 | $5,800 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | Sell | 400 | $36,000 |
Source: SEC Form 4 filings · as of 2026-09-03